The Effect of Special Discharge Training in the COVID-19
NCT ID: NCT05867485
Last Updated: 2023-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2022-04-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The central idea of this study is that providing specialized discharge education to geriatric patients in COVID-19 wards can result in improvements in their daily life activities and quality of life. The main findings of the study demonstrate a significant enhancement in daily life activities and quality of life among patients who received specialized discharge education. These individuals exhibited increased independence in mobility, improved performance in daily life activities, and reported an overall improvement in their quality of life.
These findings underscore the significance of specialized discharge education for geriatric patients hospitalized in COVID-19 wards and highlight its positive impact on their health outcomes and quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects Of Discharge Education Program On Recovery And Quality Of Life After Cardiac Surgery
NCT05631340
The Effect of Simulation to Improve of Nurse's Attitudes Towards Elderly Patient
NCT05485389
Handwashing Knowledge and Practice of Palliative Care
NCT05848596
Effectiveness of Education Given to Patients With Hemodialysis Patients
NCT06534476
The Effect of Discharge Training on Surgical Recovery in Oncology Patients
NCT04862104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and Methods: A quasi-experimental study was conducted on geriatric patients admitted to a training and research hospital's COVID-19 ward between April 1 and July 1, 2022. A control group of 40 individuals and a study group of 40 individuals, both meeting the inclusion criteria, were established. Research data were collected using the Descriptive Features Form, Katz Index of Independence in Activities of Daily Living, and SF-12 Quality of Life Scale.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group:
Initially, the Patient Diagnostic Information Form was completed. Patients were informed about the discharge process according to the regular ward procedure and were informed about their participation in the study after discharge.
One month later, patients were contacted by phone, and the Daily Life Activities Scale (DLAS) and Quality of Life Scale (SF-12) forms were completed during 10-15 minute conversations.
No interventions assigned to this group
Study Group:
After obtaining informed consent from the patients, they were enrolled in the study.
The COVID-19 Discharge Education Brochure, prepared by the researchers, was provided to the patients face-to-face within 10-15 minutes.
One month after the discharge education, patients were contacted by phone, and the Daily Life Activities Scale (DLAS) and Quality of Life Scale (SF-12) forms were completed.
COVID-19 Discharge Education
A discharge education brochure has been developed based on information from the literature to complement the verbal information provided to patients. The content of the education brochure includes the following:
1. Information about the spread of the virus and precautions to be taken.
2. Guidelines for cleanliness and disinfection of the environment.
3. Precautions regarding personal and wearable items.
4. Information about food and beverages.
5. Guidelines for personal hygiene practices.
6. Information about quarantine and isolation.
7. Guidelines for maintaining health and care (e.g., respiratory hygiene, cough etiquette, movement, range of motion exercises) (CDC, 2019; Ministry of Health of Turkey, 2020; CDC 2019 A-B-C-D).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID-19 Discharge Education
A discharge education brochure has been developed based on information from the literature to complement the verbal information provided to patients. The content of the education brochure includes the following:
1. Information about the spread of the virus and precautions to be taken.
2. Guidelines for cleanliness and disinfection of the environment.
3. Precautions regarding personal and wearable items.
4. Information about food and beverages.
5. Guidelines for personal hygiene practices.
6. Information about quarantine and isolation.
7. Guidelines for maintaining health and care (e.g., respiratory hygiene, cough etiquette, movement, range of motion exercises) (CDC, 2019; Ministry of Health of Turkey, 2020; CDC 2019 A-B-C-D).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The inclusion criteria for the study were as follows; Willingness to participate in the research, Age 65 and over, Hospitalized geriatric patients in the pandemic service, Openness to communication and cooperation, Sound mental health, Absence of sensory impairments such as vision, hearing, and speech.
Exclusion Criteria:
* patients who do not meet the inclusion criteria
65 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kilis 7 Aralik University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
İslam Elagöz
Research Assıstant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
islam ELAGÖZ, PhD-c
Role: PRINCIPAL_INVESTIGATOR
Kilis yesi Aralık Universty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Islam
Kilis, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AralikKilisU1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.